https://www.merodis.com/nl 2025-08-08T09:32:35+02:00 daily 1.0 https://www.merodis.com/en 2025-08-08T09:32:35+02:00 daily 1.0 https://www.merodis.com/fr 2025-08-08T09:32:35+02:00 daily 1.0 https://www.merodis.com/nl/nieuws/familiewissel-kapitaal-wegenbouwer-viabuild 2025-04-28T20:01:23+02:00 0.4 https://www.merodis.com/en/news/family-ownership-transition-road-construction-company-viabuild 2025-04-28T20:01:23+02:00 0.4 https://www.merodis.com/fr/actualites/la-societe-square-acquiert-la-moitie-des-actions-de-viabuild 2025-04-28T20:01:23+02:00 0.4 https://www.merodis.com/nl/nieuws/west-vlaamse-broers-bouwen-aan-gezondheidsconcern-met-nieuwe-overname 2025-04-28T19:58:59+02:00 0.4 https://www.merodis.com/en/news/west-flanders-brothers-build-health-conglomerate-new-acquisition 2025-04-28T19:58:59+02:00 0.4 https://www.merodis.com/fr/actualites/les-freres-de-flandre-occidentale-construisent-un-conglomerat-de-sante-avec-une-nouvelle 2025-04-28T19:58:59+02:00 0.4 https://www.merodis.com/nl/nieuws/smile-invest-aan-boord-bij-medtechbedrijf-medenvision 2025-04-28T20:07:27+02:00 0.4 https://www.merodis.com/en/news/smile-invest-joins-medtech-company-medenvision 2025-04-28T20:07:27+02:00 0.4 https://www.merodis.com/fr/actualites/smile-invest-rejoint-la-societe-de-technologie-medicale-medenvision 2025-04-28T20:07:27+02:00 0.4 https://www.merodis.com/nl/nieuws/datashift-schakelt-versnelling-hoger 2025-04-28T20:16:10+02:00 0.4 https://www.merodis.com/en/news/datashift-accelerates-growth 2025-04-28T20:16:10+02:00 0.4 https://www.merodis.com/fr/actualites/datashift-accelere-sa-croissance 2025-04-28T20:16:10+02:00 0.4 https://www.merodis.com/nl/nieuws/alcoholloze-gemberdrank-tankt-geld-bij-ab-inbev-familie 2025-04-28T20:23:44+02:00 0.4 https://www.merodis.com/en/news/non-alcoholic-ginger-drink-secures-funding-ab-inbev-family 2025-04-28T20:23:44+02:00 0.4 https://www.merodis.com/fr/actualites/la-boisson-au-gingembre-sans-alcool-obtient-un-financement-de-la-famille-ab-inbev 2025-04-28T20:23:44+02:00 0.4 https://www.merodis.com/nl/nieuws/biowebwinkel-efarmz-haalt-3-miljoen-euro-op-voor-uitbreiding-op-drukke-vlaamse-markt 2025-04-28T20:25:39+02:00 0.4 https://www.merodis.com/en/news/organic-online-grocer-efarmz-raises-eu3-million-expansion-flemish-market 2025-04-28T20:25:39+02:00 0.4 https://www.merodis.com/fr/actualites/lepicerie-biologique-en-ligne-efarmz-leve-3-millions-deuros-pour-se-developper-sur-le 2025-04-28T20:25:39+02:00 0.4 https://www.merodis.com/nl/nieuws/fonds-van-250-miljoen-euro-voor-aanpak-stadskankers 2025-04-28T20:56:48+02:00 0.4 https://www.merodis.com/en/news/eu250-million-fund-tackle-urban-blight 2025-04-28T20:56:48+02:00 0.4 https://www.merodis.com/fr/actualites/un-fonds-de-250-millions-deuros-pour-lutter-contre-la-degradation-des-villes 2025-04-28T20:56:48+02:00 0.4 https://www.merodis.com/nl/nieuws/creafund-koopt-west-vlaams-verpakkingsbedrijf-coeman 2025-04-28T20:30:20+02:00 0.4 https://www.merodis.com/en/news/creafund-acquires-west-flanders-based-packaging-company-coeman 2025-04-28T20:30:20+02:00 0.4 https://www.merodis.com/fr/actualites/creafund-acquiert-la-societe-demballage-coeman-basee-en-flandre-occidentale 2025-04-28T20:30:20+02:00 0.4 https://www.merodis.com/nl/nieuws/nederlandse-miljardairsfamilie-legt-hand-op-zonnekind-en-vlaamse-filmpjes 2025-04-28T20:32:11+02:00 0.4 https://www.merodis.com/en/news/dutch-billionaire-family-acquires-zonnekind-and-vlaamse-filmpjes 2025-04-28T20:32:11+02:00 0.4 https://www.merodis.com/fr/actualites/une-famille-de-milliardaires-neerlandais-acquiert-zonnekind-et-vlaamse-filmpjes 2025-04-28T20:32:11+02:00 0.4 https://www.merodis.com/nl/nieuws/gokbedrijf-golden-palace-dicht-bij-overname-press-shops-en-relays 2025-04-28T20:36:20+02:00 0.4 https://www.merodis.com/en/news/golden-palace-close-acquiring-press-shops-and-relay-stores 2025-04-28T20:36:20+02:00 0.4 https://www.merodis.com/fr/actualites/golden-palace-proche-de-lacquisition-press-shops-et-relay-stores 2025-04-28T20:36:20+02:00 0.4 https://www.merodis.com/nl/nieuws/investeringsgroep-3i-koopt-belgisch-farmabedrijf 2025-04-28T20:43:06+02:00 0.4 https://www.merodis.com/en/news/investment-group-3i-acquires-belgian-pharmaceutical-company 2025-04-28T20:43:06+02:00 0.4 https://www.merodis.com/fr/actualites/le-groupe-dinvestissement-3i-acquiert-une-societe-pharmaceutique-belge 2025-04-28T20:43:06+02:00 0.4 https://www.merodis.com/nl/nieuws/dpg-media-en-rossel-bieden-samen-op-rtl-belgie 2025-04-28T20:44:30+02:00 0.4 https://www.merodis.com/en/news/dpg-media-and-rossel-jointly-bid-rtl-belgium 2025-04-28T20:44:30+02:00 0.4 https://www.merodis.com/fr/actualites/dpg-media-et-rossel-font-une-offre-commune-pour-rtl-belgium 2025-04-28T20:44:30+02:00 0.4 https://www.merodis.com/nl/nieuws/coucke-stapt-snelgroeiend-uitvindersbedrijf-comate 2025-04-28T20:46:28+02:00 0.4 https://www.merodis.com/en/news/coucke-invests-fast-growing-inventors-company-comate 2025-04-28T20:46:28+02:00 0.4 https://www.merodis.com/fr/actualites/coucke-investit-dans-comate-une-societe-dinventeurs-en-pleine-expansion 2025-04-28T20:46:28+02:00 0.4 https://www.merodis.com/nl/nieuws/gold-forex-de-nieuwe-speerpunt-van-enkele-ex-frere-boys 2025-04-28T20:48:11+02:00 0.4 https://www.merodis.com/en/news/gold-forex-becomes-new-focus-former-frere-executives 2025-04-28T20:48:11+02:00 0.4 https://www.merodis.com/fr/actualites/gold-forex-devient-le-nouveau-centre-dinteret-des-anciens-cadres-de-frere 2025-04-28T20:48:11+02:00 0.4 https://www.merodis.com/nl/nieuws/fiets-stichter-investeert-brusselse-e-plooifiets-ahooga 2025-04-28T20:50:30+02:00 0.4 https://www.merodis.com/en/news/fiets-founder-invests-brussels-based-e-folding-bike-company-ahooga 2025-04-28T20:50:30+02:00 0.4 https://www.merodis.com/fr/actualites/le-fondateur-de-fiets-investit-dans-la-societe-bruxelloise-de-velos-pliants-ahooga 2025-04-28T20:50:30+02:00 0.4 https://www.merodis.com/nl/nieuws/belfius-zet-achtervolging-op-immoweb 2025-04-28T20:52:39+02:00 0.4 https://www.merodis.com/en/news/belfius-sets-its-sights-immoweb 2025-04-28T20:52:39+02:00 0.4 https://www.merodis.com/fr/actualites/belfius-sinteresse-immoweb 2025-04-28T20:52:39+02:00 0.4 https://www.merodis.com/nl/nieuws/techparel-newtec-singaporese-handen 2025-04-28T20:58:59+02:00 0.4 https://www.merodis.com/en/news/belgian-tech-gem-newtec-acquired-singaporean-group 2025-04-28T20:58:59+02:00 0.4 https://www.merodis.com/fr/actualites/le-groupe-singapourien-rachete-le-fleuron-technologique-belge-newtec 2025-04-28T20:58:59+02:00 0.4 https://www.merodis.com/nl/nieuws/meestersymfonie-bedrijfsoverdrachten 2025-04-28T20:00:44+02:00 0.4 https://www.merodis.com/en/news/masterful-symphony-business-transfers 2025-04-28T20:00:44+02:00 0.4 https://www.merodis.com/fr/actualites/symphonie-magistrale-dans-les-transferts-dentreprise 2025-04-28T20:00:44+02:00 0.4 https://www.merodis.com/nl/nieuws/met-een-ma-adviseur-geraak-je-verder 2025-04-28T20:20:54+02:00 0.4 https://www.merodis.com/en/news/ma-advisor-you-go-further 2025-04-28T20:20:54+02:00 0.4 https://www.merodis.com/fr/actualites/avec-un-conseiller-en-fusions-et-acquisitions-vous-allez-plus-loin 2025-04-28T20:20:54+02:00 0.4 https://www.merodis.com/nl/nieuws/de-juiste-keuze-voor-bedrijfsoverdracht 2025-04-28T20:06:21+02:00 0.4 https://www.merodis.com/en/news/right-choice-business-transfer 2025-04-28T20:06:21+02:00 0.4 https://www.merodis.com/fr/actualites/le-bon-choix-pour-le-transfert-dentreprise 2025-04-28T20:06:21+02:00 0.4 https://www.merodis.com/nl/nieuws/zo-brengt-merodis-jouw-volle-ondernemerschap-terug 2025-04-28T20:10:49+02:00 0.4 https://www.merodis.com/en/news/how-merodis-reignites-your-full-entrepreneurial-spirit 2025-04-28T20:10:49+02:00 0.4 https://www.merodis.com/fr/actualites/comment-merodis-ravive-votre-esprit-dentreprise 2025-04-28T20:10:49+02:00 0.4 https://www.merodis.com/nl/nieuws/video-interview-merodis-kanaal-z 2025-04-28T19:56:46+02:00 0.4 https://www.merodis.com/en/news/video-interview-merodis-kanaal-z 2025-04-28T19:56:46+02:00 0.4 https://www.merodis.com/fr/actualites/interview-video-merodis-canal-z 2025-04-28T19:56:46+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-verhaeren-family-sale-its-50-stake-viabuild-square-group 2025-05-14T12:26:52+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-familie-verhaeren-bij-de-verkoop-van-haar-50-belang-viabuild-aan-square 2025-05-14T12:27:12+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-la-famille-verhaeren-sur-la-vente-de-sa-participation-de-50-dans 2025-05-14T12:27:38+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-hazgo-bij-de-verkoop-aan-sgs 2025-05-14T12:28:36+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-hazgo-its-sale-sgs 2025-05-14T12:28:36+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-hazgo-sur-la-vente-sgs 2025-05-14T12:28:36+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-laboratoires-trenker-bij-de-verkoop-aan-eruditehealth 2025-05-14T12:30:53+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-laboratoires-trenker-its-sale-eruditehealth 2025-05-14T12:30:53+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-laboratoires-trenker-lors-de-leur-vente-eruditehealth 2025-05-14T12:30:53+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-medenvision-succesvol-over-partnership-met-smile-invest 2025-05-14T12:32:19+02:00 0.4 https://www.merodis.com/en/news/merodis-successfully-advises-medenvision-its-partnership-smile-invest 2025-05-14T12:32:19+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-medenvision-sur-son-partenariat-avec-smile-invest 2025-05-14T12:32:19+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-datashift-succesvol-over-samenwerking-met-finco 2025-05-14T12:33:48+02:00 0.4 https://www.merodis.com/en/news/merodis-successfully-advises-datashift-its-partnership-finco 2025-05-14T12:33:48+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-avec-succes-datashift-sur-son-partenariat-avec-finco 2025-05-14T12:33:48+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-de-aandeelhouders-van-mid-finance-bij-de-samenwerking-met-meilleurtaux 2025-05-14T12:35:47+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-mid-finance-shareholders-its-partnership-meilleurtaux 2025-05-14T12:35:47+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-de-mid-finance-sur-le-partenariat-avec-meilleurtaux 2025-05-14T12:35:47+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-verzekert-eur-10m-financiering-voor-gimber 2025-05-14T12:38:07+02:00 0.4 https://www.merodis.com/en/news/merodis-secures-eur-10m-financing-gimber 2025-05-14T12:38:07+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-obtient-un-financement-de-10-millions-deuros-pour-gimber 2025-05-14T12:38:07+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-begeleidde-efarmz-bij-zijn-kapitaalverhoging-en-private-plaatsing-van-bestaande 2025-05-14T12:39:51+02:00 0.4 https://www.merodis.com/en/news/merodis-assisted-efarmz-its-capital-increase-and-private-placement-existing-shares 2025-05-14T12:39:51+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-assiste-efarmz-dans-son-augmentation-de-capital-et-son-placement-prive-dactions 2025-05-14T12:39:51+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-revive-bijgestaan-bij-de-fondsenwerving-voor-het-good-life-development-fund-ii 2025-05-14T12:41:23+02:00 0.4 https://www.merodis.com/en/news/merodis-assisted-revive-fund-raising-its-good-life-development-fund-ii 2025-05-14T12:41:23+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-assiste-revive-dans-sa-collecte-de-fonds-pour-le-good-life-development-fund-ii 2025-05-14T12:41:23+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-de-aandeelhouders-van-coeman-over-de-samenwerking-met-creafund 2025-05-14T12:43:27+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-coemans-shareholders-partnership-creafund 2025-05-14T12:43:27+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-de-coeman-dans-le-cadre-de-la-collaboration-avec 2025-05-14T12:43:27+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-de-aandeelhouders-van-uitgeverij-averbodeeditions-erasme-bij-de-verkoop 2025-05-14T12:45:15+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-uitgeverij-averbodeseditions-erasmes-shareholders-sale-plantyn 2025-05-14T12:45:15+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-de-uitgeverij-averbodeeditions-erasme-lors-de-la 2025-05-14T12:45:15+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-golden-palace-bij-de-overname-van-ubiway-retail 2025-05-14T12:47:46+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-golden-palace-its-acquisition-ubiway-retail 2025-05-14T12:47:46+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-golden-palace-pour-lacquisition-dubiway-retail 2025-05-14T12:47:46+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-de-aandeelhouders-van-vaneflon-bij-de-verkoop-aan-een-private 2025-05-14T15:09:47+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-vaneflons-shareholders-sale-private-investor 2025-05-14T15:09:47+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-de-vaneflon-dans-la-cession-un-investisseur-prive 2025-05-14T15:09:47+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-de-aandeelhouders-van-ixx-pharma-bij-de-verkoop-aan-havea 2025-05-14T15:12:04+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-ixx-pharma-shareholders-sale-havea 2025-05-14T15:12:04+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-dixx-pharma-lors-de-la-vente-havea 2025-05-14T15:12:04+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-groupe-rossel-bij-de-gezamenlijke-overname-van-rtl-belgium 2025-05-14T15:13:27+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-groupe-rossel-joint-takeover-rtl-belgium 2025-05-14T15:13:27+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-le-groupe-rossel-pour-lacquisition-conjointe-de-rtl-belgium 2025-05-14T15:13:27+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-comate-bij-unieke-samenwerking-met-alychlo-nv 2025-05-14T15:20:30+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-comate-unique-partnership-deal-alychlo-nv 2025-05-14T15:20:30+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-comate-dans-le-cadre-dun-partenariat-unique-avec-alychlo-nv 2025-05-14T15:20:30+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-de-aandeelhouders-van-certisys-bij-de-verkoop-aan-ecocert-group 2025-05-14T15:21:54+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-certisys-shareholders-sale-ecocert-group 2025-05-14T15:21:54+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-de-certisys-lors-de-la-vente-au-groupe-ecocert 2025-05-14T15:21:54+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-de-aandeelhouders-van-gold-forex-international-sa-bij-de-verkoop-aan 2025-05-14T15:23:08+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-gold-forex-international-sas-shareholders-sale-whitestone-partners-srl 2025-05-14T15:23:08+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-de-gold-forex-international-sa-lors-de-la-vente 2025-05-14T15:23:08+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-aandeelhouders-ahooga-bij-verkoop-belang-aan-freshmen 2025-05-14T15:24:31+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-ahoogas-shareholders-sale-equity-stake-freshmen 2025-05-14T15:24:31+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-dahooga-sur-la-vente-de-leur-participation-freshmen 2025-05-14T15:24:31+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-de-aandeelhouders-van-immovlan-rossel-en-roularta-bij-de-verkoop-van-een 2025-05-14T15:25:59+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-immovlans-shareholders-rossel-and-roularta-sale-30-minority-stake-belfius 2025-05-14T15:25:59+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-dimmovlan-rossel-et-roularta-sur-la-vente-dune 2025-05-14T15:25:59+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-treedt-op-als-arranger-bij-de-private-plaatsing-van-een-eur5m-5y-note-voor-atenor 2025-05-14T15:27:33+02:00 0.4 https://www.merodis.com/en/news/merodis-acts-arranger-private-placement-eur5m-5y-note-atenor 2025-05-14T15:27:33+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-intervient-en-tant-quarrangeur-dans-le-placement-prive-dune-obligation-5-ans-de 2025-05-14T15:27:33+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-treedt-op-als-arranger-bij-de-onderhandse-plaatsing-van-een-obligatielening-van-eur 2025-05-14T15:31:09+02:00 0.4 https://www.merodis.com/en/news/merodis-acts-arranger-private-placement-eur-5m-bond-audiovalley 2025-05-14T15:31:09+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-intervient-en-tant-quarrangeur-dans-le-placement-prive-dun-emprunt-obligataire 2025-05-14T15:31:09+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-de-aandeelhouders-van-medipartner-bij-de-verkoop-aan-we-are-jane 2025-05-14T15:32:34+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-medipartners-shareholders-sale-we-are-jane 2025-05-14T15:32:34+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-les-actionnaires-de-medipartner-dans-la-cession-we-are-jane 2025-05-14T15:32:34+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-vesale-pharma-bij-de-verkoop-van-haar-antitranspirantendivisie-aan 2025-05-14T15:34:02+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-vesale-pharma-carve-out-its-antiperspirant-business 2025-05-14T15:34:02+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-vesale-pharma-lors-de-la-vente-de-sa-division-anti-transpirants 2025-05-14T15:34:02+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-laboratoire-gifrer-bij-de-afsplitsing-van-zijn-ophtalmic-activiteiten 2025-05-14T15:35:18+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-laboratoire-gifrer-carve-out-its-ophtalmic-business 2025-05-14T15:35:18+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-le-laboratoire-gifrer-pour-la-cession-de-son-activite-ophtalmic 2025-05-14T15:35:18+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-verkoop-newtec-aan-st-engineering-voor-eur-250m 2025-05-14T15:36:43+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-sale-newtec-st-engineering-eur-250m 2025-05-14T15:36:43+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-recommande-la-vente-de-newtec-st-engineering-pour-250-millions-deuros 2025-05-14T15:36:43+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-one-smart-control-nv-bij-de-fusie-met-digitalstrom 2025-05-14T15:38:27+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-one-smart-control-nv-its-merger-digitalstrom 2025-05-14T15:38:27+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-one-smart-control-nv-sur-la-fusion-avec-digitalstrom 2025-05-14T15:38:27+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-bij-de-verkoop-van-ets-ronveaux-aan-groupe-wanty 2025-05-14T15:49:13+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-sale-ets-ronveaux-groupe-wanty 2025-05-14T15:49:13+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-la-vente-des-ets-ronveaux-au-groupe-wanty 2025-05-14T15:49:13+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-bij-de-verkoop-van-rmn-aan-vivactis 2025-05-14T15:50:51+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-sale-rmn-vivactis 2025-05-14T15:50:51+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-la-vente-de-rmn-vivactis 2025-05-14T15:50:51+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-begeleidt-pom-nv-bij-haar-financieringsronde 2025-05-14T15:52:19+02:00 0.4 https://www.merodis.com/en/news/merodis-assists-pom-nv-its-financing-round 2025-05-14T15:52:19+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-accompagne-pom-nv-dans-son-cycle-de-financement 2025-05-14T15:52:19+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-begeleidt-kebony-bij-financieringsronde-van-10-miljoen-eur 2025-05-14T15:55:07+02:00 0.4 https://www.merodis.com/en/news/merodis-assists-kebony-its-eur-10m-financing-round 2025-05-14T15:55:07+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-accompagne-kebony-dans-un-tour-de-table-de-10-millions-deuros 2025-05-14T15:55:07+02:00 0.4 https://www.merodis.com/nl/nieuws/iba-radioisotopes-france-sas-belangrijkste-activa-verkocht-aan-cermep 2025-05-14T16:02:58+02:00 0.4 https://www.merodis.com/en/news/iba-radioisotopes-france-sas-key-assets-sold-cermep 2025-05-14T16:02:58+02:00 0.4 https://www.merodis.com/fr/actualites/iba-radioisotopes-france-sas-vente-des-principaux-actifs-cermep 2025-05-14T16:02:58+02:00 0.4 https://www.merodis.com/nl/nieuws/bpl-verkocht-aan-buysse-partners 2025-05-14T16:08:49+02:00 0.4 https://www.merodis.com/en/news/bpl-sold-buysse-partners 2025-05-14T16:08:49+02:00 0.4 https://www.merodis.com/fr/actualites/bpl-vendue-buysse-partners 2025-05-14T16:08:49+02:00 0.4 https://www.merodis.com/nl/nieuws/biocode-hycel-verkocht-aan-ids 2025-05-14T16:12:11+02:00 0.4 https://www.merodis.com/en/news/biocode-hycel-sold-ids 2025-05-14T16:12:11+02:00 0.4 https://www.merodis.com/fr/actualites/biocode-hycel-vendu-aux-ids 2025-05-14T16:12:11+02:00 0.4 https://www.merodis.com/nl/nieuws/pet-net-verkocht-aan-iba 2025-05-14T16:19:06+02:00 0.4 https://www.merodis.com/en/news/pet-net-sold-iba 2025-05-14T16:19:06+02:00 0.4 https://www.merodis.com/fr/actualites/pet-net-vendu-iba 2025-05-14T16:19:06+02:00 0.4 https://www.merodis.com/nl/nieuws/fft-verkocht-aan-msc-software 2025-05-14T16:22:14+02:00 0.4 https://www.merodis.com/en/news/fft-sold-msc-software 2025-05-14T16:22:14+02:00 0.4 https://www.merodis.com/fr/actualites/fft-vendu-msc-software 2025-05-14T16:22:14+02:00 0.4 https://www.merodis.com/nl/nieuws/brandialog-financiering-private-placement 2025-05-14T16:23:29+02:00 0.4 https://www.merodis.com/en/news/brandialog-financing-through-private-placement 2025-05-14T16:23:29+02:00 0.4 https://www.merodis.com/fr/actualites/brandialog-financement-par-placement-prive 2025-05-14T16:23:29+02:00 0.4 https://www.merodis.com/nl/nieuws/yago-schuldfinanciering-private-placement 2025-05-14T16:28:34+02:00 0.4 https://www.merodis.com/en/news/yago-debt-financing-through-private-placement 2025-05-14T16:28:34+02:00 0.4 https://www.merodis.com/fr/actualites/yago-financement-par-la-dette-un-placement-prive 2025-05-14T16:28:34+02:00 0.4 https://www.merodis.com/nl/nieuws/groupe-bertrand-schuldfinanciering-private-plaatsing 2025-05-14T16:30:53+02:00 0.4 https://www.merodis.com/en/news/groupe-bertrand-debt-financing-through-private-placement 2025-05-14T16:30:53+02:00 0.4 https://www.merodis.com/fr/actualites/groupe-bertrand-financement-de-la-dette-par-placement-prive 2025-05-14T16:30:53+02:00 0.4 https://www.merodis.com/nl/nieuws/hld-europe-schuldfinanciering-private-placement 2025-05-14T16:32:40+02:00 0.4 https://www.merodis.com/en/news/hld-europe-debt-financing-through-private-placement 2025-05-14T16:32:40+02:00 0.4 https://www.merodis.com/fr/actualites/hld-europe-financement-de-la-dette-par-placement-prive 2025-05-14T16:32:40+02:00 0.4 https://www.merodis.com/nl/nieuws/laboratoire-aerts-filot-verkocht-aan-chequers-capital 2025-05-14T16:34:01+02:00 0.4 https://www.merodis.com/en/news/laboratoire-aerts-filot-sold-chequers-capital 2025-05-14T16:34:01+02:00 0.4 https://www.merodis.com/fr/actualites/le-laboratoire-aerts-filot-vendu-chequers-capital 2025-05-14T16:34:01+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-exclusief-adviseur-bij-de-verkoop-van-medsys 2025-05-14T16:36:12+02:00 0.4 https://www.merodis.com/en/news/merodis-exclusive-advisor-sale-medsys 2025-05-14T16:36:12+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseiller-exclusif-pour-la-vente-de-medsys 2025-05-14T16:36:12+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-trad-op-als-exclusief-adviseur-bij-de-verkoop-van-e-xstream-engineering-aan-het 2025-05-14T16:38:18+02:00 0.4 https://www.merodis.com/en/news/merodis-acted-exclusive-advisor-sale-e-xstream-engineering-us-based-msc-software 2025-05-14T16:38:18+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-agi-en-tant-que-conseiller-exclusif-dans-la-vente-de-xstream-engineering-la 2025-05-14T16:38:18+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-telemis-bij-haar-management-buy-out 2025-05-14T16:39:57+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-telemis-its-management-buyout 2025-05-14T16:39:57+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-telemis-dans-le-cadre-de-son-rachat-par-les-cadres 2025-05-14T16:39:57+02:00 0.4 https://www.merodis.com/nl/nieuws/mbo-van-altissia-merodis-trad-op-als-exclusief-adviseur-van-cll-language-centres-ucl-102 2025-05-14T16:41:35+02:00 0.4 https://www.merodis.com/en/news/mbo-altissia-merodis-acted-exclusive-advisor-cll-language-centres-ucl 2025-05-14T16:41:35+02:00 0.4 https://www.merodis.com/fr/actualites/mbo-daltissia-merodis-agi-en-tant-que-consultant-exclusif-pour-cll-language-centres-ucl 2025-05-14T16:41:35+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-legendre-conveyors-bij-de-strategische-overname-van-belangrijke-activa 2025-05-14T16:45:21+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-legendre-conveyors-its-strategic-takeover-key-assets-pcs 2025-05-14T16:45:21+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-legendre-conveyors-sur-lacquisition-strategique-dactifs-cles-de-pcs 2025-05-14T16:45:21+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-van-de-arterin-activiteiten-van-pharco-aan-omega-pharma-uitgevoerd 2025-05-14T16:46:44+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-pharcos-arterin-business-omega-pharma-eur-10m 2025-05-14T16:46:44+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-execute-la-vente-de-lactivite-arterin-de-pharco-omega-pharma-pour-un-montant-de 2025-05-14T16:46:44+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-afgerond-van-de-farmaceutische-activa-van-erfa-sa 2025-05-14T16:53:35+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-pharmaceutical-assets-erfa-sa 2025-05-14T16:53:35+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-finalise-la-vente-des-actifs-pharmaceutiques-derfa-sa 2025-05-14T16:53:35+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-van-despharma-aan-omega-pharma-uitgevoerd 2025-05-14T16:55:25+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-despharma-omega-pharma 2025-05-14T16:55:25+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-execute-la-vente-de-despharma-omega-pharma 2025-05-14T16:55:25+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-biosourcing-succesvol-bij-kapitaalverhoging 2025-05-14T16:56:55+02:00 0.4 https://www.merodis.com/en/news/merodis-successfully-advises-biosourcing-its-capital-increase 2025-05-14T16:56:55+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-avec-succes-biosourcing-dans-le-cadre-dune-augmentation-de-capital 2025-05-14T16:56:55+02:00 0.4 https://www.merodis.com/nl/nieuws/pharco-haalt-eur-15m-aan-schuldfinanciering-op-en-tekent-een-commercieel-partnerschap 2025-05-14T16:58:26+02:00 0.4 https://www.merodis.com/en/news/pharco-raises-eur-15m-debt-financing-and-signs-commercial-partnership 2025-05-14T16:58:26+02:00 0.4 https://www.merodis.com/fr/actualites/pharco-leve-15-million-deuros-de-financement-et-signe-un-partenariat-commercial 2025-05-14T16:58:26+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-begeleidt-fng-bij-kapitaalverhoging-van-30-miljoen-eur 2025-05-14T17:00:28+02:00 0.4 https://www.merodis.com/en/news/merodis-assists-fng-its-eur-30m-capital-raise 2025-05-14T17:00:28+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-assiste-fng-dans-une-augmentation-de-capital-de-30-millions-deuros 2025-05-14T17:00:28+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-begeleidt-fintech-koalaboox-bij-plaatsing-obligatielening-van-13-miljoen-euro 2025-05-14T17:02:34+02:00 0.4 https://www.merodis.com/en/news/merodis-assists-fintech-koalaboox-its-eur-13-million-bond-placing 2025-05-14T17:02:34+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-accompagne-la-fintech-koalaboox-dans-un-placement-obligataire-de-13-millions 2025-05-14T17:02:34+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-het-amerikaanse-onssi-bij-de-overname-van-seetec 2025-05-14T17:03:21+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-us-based-onssi-its-acquisition-seetec 2025-05-14T17:03:21+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-lentreprise-americaine-onssi-lors-de-lacquisition-de-seetec 2025-05-14T17:03:21+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-uitgevoerd-van-ascolia-group-aan-icarus-invest 2025-05-14T17:04:02+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-ascolia-group-icarus-invest 2025-05-14T17:04:02+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-execute-la-vente-du-groupe-ascolia-icarus-invest 2025-05-14T17:04:02+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-realiseerde-de-verkoop-van-kntv-aan-everlasting-prod 2025-05-14T17:05:32+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-kntv-everlasting-prod 2025-05-14T17:05:32+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-realise-la-vente-de-kntv-everlasting-prod 2025-05-14T17:05:32+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-verkoop-redpharma-aan-groupe-rossel 2025-05-14T17:06:03+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-sale-redpharma-groupe-rossel 2025-05-14T17:06:03+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-la-vente-de-redpharma-au-groupe-rossel 2025-05-14T17:06:03+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-van-labima-aan-vemedia-group-uitgevoerd 2025-05-14T17:06:43+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-labima-vemedia-group 2025-05-14T17:06:43+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-execute-la-vente-de-labima-vemedia-group 2025-05-14T17:06:43+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-optimalis-group-bij-de-mbo 2025-05-14T17:07:38+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-optimalis-group-mbo 2025-05-14T17:07:38+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-le-groupe-optimalis-dans-le-cadre-du-mbo 2025-05-14T17:07:38+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-van-qustomer-aan-ing-uitgevoerd 2025-05-14T17:08:24+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-qustomer-ing 2025-05-14T17:08:24+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-execute-la-vente-de-qustomer-ing 2025-05-14T17:08:24+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-van-euro-m-aan-een-prive-investeerder-uitgevoerd 2025-05-14T17:09:09+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-euro-m-private-investor 2025-05-14T17:09:09+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-execute-la-vente-deuro-m-un-investisseur-prive 2025-05-14T17:09:09+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-verkoop-pulssar-technologies-aan-tecan 2025-05-14T17:10:14+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-sale-pulssar-technologies-tecan 2025-05-14T17:10:14+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-recommande-la-vente-de-pulssar-technologies-tecan 2025-05-14T17:10:14+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-verkoop-meerderheidsbelang-newtec-aan-pmv-smartfin 2025-05-14T17:11:20+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-sale-majority-stake-newtec-pmv-smartfin 2025-05-14T17:11:20+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-recommande-la-vente-de-sa-participation-majoritaire-dans-newtec-pmv-smartfin 2025-05-14T17:11:20+02:00 0.4 https://www.merodis.com/nl/nieuws/pharco-verkoopt-zijn-totale-productportfolio-voor-eur-85m 2025-05-14T17:11:30+02:00 0.4 https://www.merodis.com/en/news/pharco-sells-its-overall-product-portfolio-eur-85m 2025-05-14T17:11:30+02:00 0.4 https://www.merodis.com/fr/actualites/pharco-vend-lensemble-de-son-portefeuille-de-produits-pour-85-millions-deuros 2025-05-14T17:11:30+02:00 0.4 https://www.merodis.com/nl/nieuws/3-miljoen-euro-financieringspakket-voor-tehr 2025-05-14T17:12:33+02:00 0.4 https://www.merodis.com/en/news/eur-3m-financing-package-tehr 2025-05-14T17:12:33+02:00 0.4 https://www.merodis.com/fr/actualites/financement-de-3-millions-deuros-pour-tehr 2025-05-14T17:12:33+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-realiseerde-de-verkoop-van-codabox-aan-isabel-group 2025-05-14T17:13:46+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-codabox-isabel-group 2025-05-14T17:13:46+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-realise-la-vente-de-codabox-au-groupe-isabel 2025-05-14T17:13:46+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseerde-sophia-genetics-bij-haar-serie-c-financiering-van-chf-15m 2025-05-14T17:14:40+02:00 0.4 https://www.merodis.com/en/news/merodis-advised-sophia-genetics-its-chf-15m-series-c-financing 2025-05-14T17:14:40+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-sophia-genetics-pour-son-financement-de-serie-c-de-chf-15-millions 2025-05-14T17:14:40+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-voerde-de-verkoop-uit-van-de-activiteiten-van-immunehealth-aan-caprion-biosciences 2025-05-14T17:15:10+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-immunehealths-activities-caprion-biosciences 2025-05-14T17:15:10+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-mene-la-vente-des-activites-dimmunehealth-caprion-biosciences 2025-05-14T17:15:10+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-van-de-animal-health-activiteiten-van-oystershell-uitgevoerd 2025-05-14T17:16:45+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-oystershells-animal-health-business 2025-05-14T17:16:45+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-mene-la-vente-de-lactivite-sante-animale-doystershell 2025-05-14T17:16:45+02:00 0.4 https://www.merodis.com/nl/nieuws/pp-nu-beschikbaar 2025-05-14T17:16:47+02:00 0.4 https://www.merodis.com/en/news/pp-now-available 2025-05-14T17:16:47+02:00 0.4 https://www.merodis.com/fr/actualites/pp-maintenant-disponible 2025-05-14T17:16:47+02:00 0.4 https://www.merodis.com/nl/nieuws/kapitaalverhoging-van-6-miljoen-euro-voor-kiomed-pharma 2025-05-14T17:18:03+02:00 0.4 https://www.merodis.com/en/news/eur-6m-capital-increase-kiomed-pharma 2025-05-14T17:18:03+02:00 0.4 https://www.merodis.com/fr/actualites/augmentation-de-capital-de-6-millions-deuros-pour-kiomed-pharma 2025-05-14T17:18:03+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-executeert-de-handelsverkoop-van-calxx-laboratories-aan-md-pharma 2025-05-14T17:18:14+02:00 0.4 https://www.merodis.com/en/news/merodis-executes-trade-sale-calxx-laboratories-md-pharma 2025-05-14T17:18:14+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-realise-la-vente-de-calxx-laboratories-md-pharma 2025-05-14T17:18:14+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-vesale-pharma-bij-de-verkoop-aan-ceres-pharma 2025-06-06T11:00:13+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-vesale-pharma-its-sale-ceres-pharma 2025-06-06T11:00:13+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-vesale-pharma-dans-sa-vente-ceres-pharma 2025-06-06T11:00:13+02:00 0.4 https://www.merodis.com/nl/nieuws/farmabedrijf-ceres-koopt-sectorgenoot-vesale-pharma 2025-06-06T13:48:23+02:00 0.4 https://www.merodis.com/en/news/pharma-company-ceres-buys-industry-peer-vesale-pharma 2025-06-06T13:48:23+02:00 0.4 https://www.merodis.com/fr/actualites/lentreprise-pharmaceutique-ceres-achete-un-homologue-du-secteur-vesale-pharma 2025-06-06T13:48:23+02:00 0.4 https://www.merodis.com/nl/nieuws/niet-elke-bedrijfsoverdracht-een-100-procent-verkoop 2025-10-23T10:30:00+02:00 0.4 https://www.merodis.com/en/news/not-every-business-transfer-100-percent-sale 2025-10-23T10:30:00+02:00 0.4 https://www.merodis.com/fr/actualites/la-transmission-dune-entreprise-nest-pas-toujours-une-vente-100 2025-10-23T10:30:00+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-alluvion-bij-de-verkoop-aan-amista 2025-08-07T13:48:30+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-alluvion-its-sale-amista 2025-08-07T13:48:30+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-alluvion-dans-sa-vente-amista 2025-08-07T13:48:30+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-nexum-bij-de-fusie-met-proacteur-met-steun-van-profinpar-een-nieuwe 2025-09-02T16:38:42+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-nexums-merger-proacteur-support-profinpar-new-minority-shareholder 2025-09-02T16:38:42+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-nexum-sur-la-fusion-avec-proacteur-avec-le-soutien-de-profinpar-un 2025-09-02T16:38:42+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-heeft-de-verkoop-uitgevoerd-van-vemedias-abc-chemicals 2025-09-02T16:44:33+02:00 0.4 https://www.merodis.com/en/news/merodis-executed-sale-vemedias-abc-chemicals 2025-09-02T16:44:33+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-execute-la-vente-de-la-division-abc-chemicals-de-vemedia 2025-09-02T16:44:33+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-group-bij-verkoop-aan-network-aviation-group 2025-10-17T17:26:13+02:00 0.4 https://www.merodis.com/en/news/merodis-advises-group-its-sale-network-aviation-group 2025-10-17T17:26:13+02:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-group-dans-sa-vente-network-aviation-group 2025-10-17T17:26:13+02:00 0.4 https://www.merodis.com/nl/nieuws/naar-de-deal-met-het-juiste-kompas 2025-10-23T10:30:32+02:00 0.4 https://www.merodis.com/en/news/towards-deal-right-compass 2025-10-23T10:30:32+02:00 0.4 https://www.merodis.com/fr/actualites/naviguer-vers-la-transaction-avec-la-bonne-boussole 2025-10-23T10:30:32+02:00 0.4 https://www.merodis.com/nl/nieuws/merodis-adviseert-laroy-group-bij-strategisch-partnership-met-group-depre 2026-02-04T17:50:53+01:00 0.4 https://www.merodis.com/en/news/merodis-advises-laroy-group-strategic-partnership-group-depre 2026-02-04T17:50:53+01:00 0.4 https://www.merodis.com/fr/actualites/merodis-conseille-laroy-group-sur-son-partenariat-strategique-avec-group-depre 2026-02-04T17:50:53+01:00 0.4 https://www.merodis.com/nl/home 2025-08-08T09:32:35+02:00 1.0 https://www.merodis.com/en/home 2025-08-08T09:32:35+02:00 1.0 https://www.merodis.com/fr/page-daccueil 2025-08-08T09:32:35+02:00 1.0 https://www.merodis.com/nl/privacybeleid 2025-02-12T09:49:02+01:00 0.1 https://www.merodis.com/en/privacy-policy 2025-02-12T09:49:02+01:00 0.1 https://www.merodis.com/fr/politique-de-confidentialite 2025-02-12T09:49:02+01:00 0.1 https://www.merodis.com/nl/cookies 2025-02-12T09:34:31+01:00 0.1 https://www.merodis.com/en/cookies 2025-02-12T09:34:31+01:00 0.1 https://www.merodis.com/fr/cookies 2025-02-12T09:34:31+01:00 0.1 https://www.merodis.com/nl/toegang-verboden 2025-06-24T12:00:02+02:00 0.5 https://www.merodis.com/en/access-prohibited 2025-06-24T12:00:02+02:00 0.5 https://www.merodis.com/fr/acces-interdit 2025-06-24T12:00:02+02:00 0.5 https://www.merodis.com/nl/pagina-niet-gevonden 2025-06-24T11:58:51+02:00 0.5 https://www.merodis.com/en/page-was-not-found 2025-06-24T11:58:51+02:00 0.5 https://www.merodis.com/fr/page-non-trouvee 2025-06-24T11:58:51+02:00 0.5 https://www.merodis.com/nl/bedankt-dat-u-contact-met-ons-hebt-opgenomen 2025-06-24T12:02:05+02:00 0.5 https://www.merodis.com/en/thank-you-contacting-us 2025-06-24T12:02:05+02:00 0.5 https://www.merodis.com/fr/merci-de-nous-avoir-contacte 2025-06-24T12:02:05+02:00 0.5 https://www.merodis.com/nl/keukenspoelbak 2025-04-23T11:47:43+02:00 0.5 https://www.merodis.com/en/kitchensink 2025-04-23T11:47:43+02:00 0.5 https://www.merodis.com/fr/evier-de-cuisine 2025-04-23T11:47:43+02:00 0.5 https://www.merodis.com/nl/over-merodis 2025-06-12T18:08:42+02:00 0.5 https://www.merodis.com/en/about-merodis 2025-06-12T18:08:42+02:00 0.5 https://www.merodis.com/fr/propos-de-merodis 2025-06-12T18:08:42+02:00 0.5 https://www.merodis.com/nl/nieuws 2025-05-05T14:13:22+02:00 0.5 https://www.merodis.com/en/news 2025-05-05T14:13:22+02:00 0.5 https://www.merodis.com/fr/actualites 2025-05-05T14:13:22+02:00 0.5 https://www.merodis.com/nl/transacties 2025-01-08T16:27:17+01:00 0.5 https://www.merodis.com/en/transactions 2025-01-08T16:27:17+01:00 0.5 https://www.merodis.com/fr/transactions 2025-01-08T16:27:17+01:00 0.5 https://www.merodis.com/nl/verkoop-van-uw-bedrijf 2025-06-13T10:56:33+02:00 0.5 https://www.merodis.com/en/selling-your-company 2025-06-13T10:56:33+02:00 0.5 https://www.merodis.com/fr/vendre-son-entreprise 2025-06-13T10:56:33+02:00 0.5 https://www.merodis.com/nl/adviesdiensten 2025-06-13T14:16:15+02:00 0.5 https://www.merodis.com/en/advisory-services 2025-06-13T14:16:15+02:00 0.5 https://www.merodis.com/fr/services-de-conseil 2025-06-13T14:16:15+02:00 0.5 https://www.merodis.com/nl/neem-contact-op 2025-06-13T14:31:14+02:00 0.5 https://www.merodis.com/en/contact 2025-06-13T14:31:14+02:00 0.5 https://www.merodis.com/fr/prendre-contact 2025-06-13T14:31:14+02:00 0.5 https://www.merodis.com/nl/verkoop-van-uw-bedrijf/gedeeltelijke-verkoop-private-equity-partnerships 2025-06-17T10:34:58+02:00 0.5 https://www.merodis.com/en/selling-your-company/partial-sale-or-private-equity-partnerships 2025-06-17T10:34:58+02:00 0.5 https://www.merodis.com/fr/vendre-son-entreprise/vente-partielle-ou-partenariat-avec-capital-investissement-private-equity 2025-06-17T10:34:58+02:00 0.5 https://www.merodis.com/nl/verkoop-van-uw-bedrijf/volledige-verkoop-met-respect-voor-uw-nalatenschap 2025-06-17T10:33:43+02:00 0.5 https://www.merodis.com/en/selling-your-company/complete-sale-respect-your-legacy 2025-06-17T10:33:43+02:00 0.5 https://www.merodis.com/fr/vendre-son-entreprise/vente-100-en-mettant-laccent-sur-votre-heritage 2025-06-17T10:33:43+02:00 0.5 https://www.merodis.com/nl/verkoop-van-uw-bedrijf/flexibele-oplossingen-voor-een-vlotte-exit 2025-06-17T10:36:06+02:00 0.5 https://www.merodis.com/en/selling-your-company/flexible-solutions-clear-exit 2025-06-17T10:36:06+02:00 0.5 https://www.merodis.com/fr/vendre-son-entreprise/des-solutions-flexibles-pour-une-sortie-claire 2025-06-17T10:36:06+02:00 0.5 https://www.merodis.com/en/advisory-services/capital-raising 2025-03-19T12:27:10+01:00 0.5 https://www.merodis.com/nl/adviesdiensten/strategisch-financieel-advies 2025-06-17T10:37:23+02:00 0.5 https://www.merodis.com/en/advisory-services/strategic-financial-advisory 2025-06-17T10:37:23+02:00 0.5 https://www.merodis.com/fr/services-de-conseil/conseil-strategique-et-financier 2025-06-17T10:37:23+02:00 0.5 https://www.merodis.com/nl/over-merodis/team 2025-05-13T10:23:59+02:00 0.5 https://www.merodis.com/en/about-merodis/team 2025-05-13T10:23:59+02:00 0.5 https://www.merodis.com/fr/propos-de-merodis/team 2025-05-13T10:23:59+02:00 0.5 https://www.merodis.com/nl/adviesdiensten/groeifinanciering 2025-06-17T10:38:31+02:00 0.5 https://www.merodis.com/en/advisory-services/financing 2025-06-17T10:38:31+02:00 0.5 https://www.merodis.com/fr/services-de-conseil/financement 2025-06-17T10:38:31+02:00 0.5 https://www.merodis.com/nl/adviesdiensten/bedrijfswaardering 2025-06-17T10:39:30+02:00 0.5 https://www.merodis.com/en/advisory-services/company-valuation 2025-06-17T10:39:30+02:00 0.5 https://www.merodis.com/fr/services-de-conseil/valorisation-de-lentreprise 2025-06-17T10:39:30+02:00 0.5 https://www.merodis.com/nl/frederic-bethume 2025-04-25T14:35:26+02:00 0.5 https://www.merodis.com/en/frederic-bethume 2025-04-25T14:35:26+02:00 0.5 https://www.merodis.com/fr/frederic-bethume 2025-04-25T14:35:26+02:00 0.5 https://www.merodis.com/nl/victor-boes 2026-01-05T21:12:29+01:00 0.5 https://www.merodis.com/en/victor-boes 2026-01-05T21:12:29+01:00 0.5 https://www.merodis.com/fr/victor-boes 2026-01-05T21:12:29+01:00 0.5 https://www.merodis.com/nl/fabian-dhoore 2025-05-16T20:06:45+02:00 0.5 https://www.merodis.com/en/fabian-dhoore 2025-05-16T20:06:45+02:00 0.5 https://www.merodis.com/fr/fabian-dhoore 2025-05-16T20:06:45+02:00 0.5 https://www.merodis.com/nl/juliette-demey 2026-01-05T21:14:26+01:00 0.5 https://www.merodis.com/en/juliette-demey 2026-01-05T21:14:26+01:00 0.5 https://www.merodis.com/fr/juliette-demey 2026-01-05T21:14:26+01:00 0.5 https://www.merodis.com/nl/arnaud-goossens 2025-04-28T19:31:16+02:00 0.5 https://www.merodis.com/en/arnaud-goossens 2025-04-28T19:31:16+02:00 0.5 https://www.merodis.com/fr/arnaud-goossens 2025-04-28T19:31:16+02:00 0.5 https://www.merodis.com/nl/dirk-marckx 2025-08-11T09:11:42+02:00 0.5 https://www.merodis.com/en/dirk-marckx 2025-08-11T09:11:42+02:00 0.5 https://www.merodis.com/fr/dirk-marckx 2025-08-11T09:11:42+02:00 0.5 https://www.merodis.com/nl/eliah-vanhove 2026-01-05T21:14:10+01:00 0.5 https://www.merodis.com/en/eliah-vanhove 2026-01-05T21:14:10+01:00 0.5 https://www.merodis.com/fr/eliah-vanhove 2026-01-05T21:14:10+01:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-hazgo-bij-de-verkoop-aan-sgs 2025-06-10T11:30:24+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-hazgo-its-sale-sgs 2025-06-10T11:30:24+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-hazgo-sur-la-vente-sgs 2025-06-10T11:30:24+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-laboratoires-trenker-bij-de-verkoop-aan-eruditehealth 2025-06-10T11:30:49+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-laboratoires-trenker-its-sale-eruditehealth 2025-06-10T11:30:49+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-laboratoires-trenker-lors-de-leur-vente-eruditehealth 2025-06-10T11:30:49+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-medenvision-succesvol-over-partnership-met-smile-invest 2025-06-10T11:31:04+02:00 0.5 https://www.merodis.com/en/transactions/merodis-successfully-advises-medenvision-its-partnership-smile-invest 2025-06-10T11:31:04+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-medenvision-sur-son-partenariat-avec-smile-invest 2025-06-10T11:31:04+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-datashift-succesvol-over-samenwerking-met-finco 2026-02-04T18:53:45+01:00 0.5 https://www.merodis.com/en/transactions/merodis-successfully-advises-datashift-its-partnership-finco 2026-02-04T18:53:45+01:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-avec-succes-datashift-sur-son-partenariat-avec-finco 2026-02-04T18:53:45+01:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-de-aandeelhouders-van-mid-finance-bij-de-samenwerking-met 2025-06-10T11:31:55+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-mid-finance-shareholders-its-partnership-meilleurtaux 2025-06-10T11:31:55+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-de-mid-finance-sur-le-partenariat-avec-meilleurtaux 2025-06-10T11:31:55+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-begeleidde-efarmz-bij-zijn-kapitaalverhoging-en-private-plaatsing-van 2025-06-05T18:33:59+02:00 0.5 https://www.merodis.com/en/transactions/merodis-assisted-efarmz-its-capital-increase-and-private-placement-existing-shares 2025-06-05T18:33:59+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-assiste-efarmz-dans-son-augmentation-de-capital-et-son-placement-prive 2025-06-05T18:33:59+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-golden-palace-bij-de-overname-van-ubiway-retail 2025-06-10T11:33:09+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-golden-palace-its-acquisition-ubiway-retail 2025-06-10T11:33:09+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-golden-palace-pour-lacquisition-dubiway-retail 2025-06-10T11:33:09+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-de-aandeelhouders-van-coeman-over-de-samenwerking-met-creafund 2025-06-10T11:32:35+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-coemans-shareholders-partnership-creafund 2025-06-10T11:32:35+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-de-coeman-dans-le-cadre-de-la-collaboration-avec 2025-06-10T11:32:35+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-de-aandeelhouders-van-uitgeverij-averbodeeditions-erasme-bij-de 2026-02-04T18:55:28+01:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-uitgeverij-averbodeseditions-erasmes-shareholders-sale-plantyn 2026-02-04T18:55:28+01:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-de-uitgeverij-averbodeeditions-erasme-lors-de-la 2026-02-04T18:55:28+01:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-de-aandeelhouders-van-vaneflon-bij-de-verkoop-aan-een-private 2025-06-10T11:33:34+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-vaneflons-shareholders-sale-private-investor 2025-06-10T11:33:34+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-de-vaneflon-dans-la-cession-un-investisseur-prive 2025-06-10T11:33:34+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-de-aandeelhouders-van-ixx-pharma-bij-de-verkoop-aan-havea 2025-06-10T11:33:47+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-ixx-pharma-shareholders-sale-havea 2025-06-10T11:33:47+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-dixx-pharma-lors-de-la-vente-havea 2025-06-10T11:33:47+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-groupe-rossel-bij-de-gezamenlijke-overname-van-rtl-belgium 2025-06-10T11:34:04+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-groupe-rossel-joint-takeover-rtl-belgium 2025-06-10T11:34:04+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-le-groupe-rossel-pour-lacquisition-conjointe-de-rtl-belgium 2025-06-10T11:34:04+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-comate-bij-unieke-samenwerking-met-alychlo-nv 2025-06-10T11:34:19+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-comate-unique-partnership-deal-alychlo-nv 2025-06-10T11:34:19+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-comate-dans-le-cadre-dun-partenariat-unique-avec-alychlo-nv 2025-06-10T11:34:19+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-de-aandeelhouders-van-certisys-bij-de-verkoop-aan-ecocert-group 2025-06-10T11:34:35+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-certisys-shareholders-sale-ecocert-group 2025-06-10T11:34:35+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-de-certisys-lors-de-la-vente-au-groupe-ecocert 2025-06-10T11:34:35+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-de-aandeelhouders-van-gold-forex-international-sa-bij-de-verkoop-aan 2025-06-10T11:35:03+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-gold-forex-international-sas-shareholders-sale-whitestone-partners-srl 2025-06-10T11:35:03+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-de-gold-forex-international-sa-lors-de-la-vente 2025-06-10T11:35:03+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-aandeelhouders-ahooga-bij-verkoop-belang-aan-freshmen 2025-06-10T11:35:30+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-ahoogas-shareholders-sale-equity-stake-freshmen 2025-06-10T11:35:30+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-dahooga-sur-la-vente-de-leur-participation-freshmen 2025-06-10T11:35:30+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-de-aandeelhouders-van-immovlan-rossel-en-roularta-bij-de-verkoop-van 2025-06-05T18:34:51+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-immovlans-shareholders-rossel-and-roularta-sale-30-minority-stake 2025-06-05T18:34:51+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-dimmovlan-rossel-et-roularta-sur-la-vente-dune 2025-06-05T18:34:51+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-de-aandeelhouders-van-medipartner-bij-de-verkoop-aan-we-are-jane 2025-06-10T11:36:05+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-medipartners-shareholders-sale-we-are-jane 2025-06-10T11:36:05+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-les-actionnaires-de-medipartner-dans-la-cession-we-are-jane 2025-06-10T11:36:05+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-vesale-pharma-bij-de-verkoop-van-haar-antitranspirantendivisie-aan 2025-06-05T18:36:41+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-vesale-pharma-carve-out-its-antiperspirant-business 2025-06-05T18:36:41+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-vesale-pharma-lors-de-la-vente-de-sa-division-anti-transpirants 2025-06-05T18:36:41+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-laboratoire-gifrer-bij-de-afsplitsing-van-zijn-ophtalmic 2025-06-05T18:37:05+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-laboratoire-gifrer-carve-out-its-ophtalmic-business 2025-06-05T18:37:05+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-le-laboratoire-gifrer-pour-la-cession-de-son-activite-ophtalmic 2025-06-05T18:37:05+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-verkoop-newtec-aan-st-engineering-voor-eur-250m 2025-06-11T09:43:59+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-sale-newtec-st-engineering-eur-250m 2025-06-11T09:43:59+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-recommande-la-vente-de-newtec-st-engineering-pour-250-millions-deuros 2025-06-11T09:43:59+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-one-smart-control-nv-bij-de-fusie-met-digitalstrom 2025-06-11T09:43:05+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-one-smart-control-nv-its-merger-digitalstrom 2025-06-11T09:43:05+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-one-smart-control-nv-sur-la-fusion-avec-digitalstrom 2025-06-11T09:43:05+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-bij-de-verkoop-van-ets-ronveaux-aan-groupe-wanty 2025-06-11T09:41:58+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-sale-ets-ronveaux-groupe-wanty 2025-06-11T09:41:58+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-la-vente-des-ets-ronveaux-au-groupe-wanty 2025-06-11T09:41:58+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-bij-de-verkoop-van-rmn-aan-vivactis 2025-06-11T09:19:56+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-sale-rmn-vivactis 2025-06-11T09:19:56+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-la-vente-de-rmn-vivactis 2025-06-11T09:19:56+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-uitgevoerd-van-ascolia-group-aan-icarus-invest 2025-06-11T09:20:36+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-ascolia-group-icarus-invest 2025-06-11T09:20:36+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-execute-la-vente-du-groupe-ascolia-icarus-invest 2025-06-11T09:20:36+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-verkoop-redpharma-aan-groupe-rossel 2025-06-11T09:46:22+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-sale-redpharma-groupe-rossel 2025-06-11T09:46:22+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-la-vente-de-redpharma-au-groupe-rossel 2025-06-11T09:46:22+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-optimalis-group-bij-de-mbo 2025-06-11T09:46:55+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-optimalis-group-mbo 2025-06-11T09:46:55+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-le-groupe-optimalis-dans-le-cadre-du-mbo 2025-06-11T09:46:55+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-van-euro-m-aan-een-prive-investeerder-uitgevoerd 2025-06-11T09:47:30+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-euro-m-private-investor 2025-06-11T09:47:30+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-execute-la-vente-deuro-m-un-investisseur-prive 2025-06-11T09:47:30+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-verkoop-pulssar-technologies-aan-tecan 2025-06-11T09:22:31+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-sale-pulssar-technologies-tecan 2025-06-11T09:22:31+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-recommande-la-vente-de-pulssar-technologies-tecan 2025-06-11T09:22:31+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-verkoop-meerderheidsbelang-newtec-aan-pmv-smartfin 2025-06-11T09:48:00+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-sale-majority-stake-newtec-pmv-smartfin 2025-06-11T09:48:00+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-recommande-la-vente-de-sa-participation-majoritaire-dans-newtec-pmv-smartfin 2025-06-11T09:48:00+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-realiseerde-de-verkoop-van-codabox-aan-isabel-group 2025-06-11T09:23:11+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-codabox-isabel-group 2025-06-11T09:23:11+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-realise-la-vente-de-codabox-au-groupe-isabel 2025-06-11T09:23:11+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-voerde-de-verkoop-uit-van-de-activiteiten-van-immunehealth-aan-caprion 2025-06-05T18:38:38+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-immunehealths-activities-caprion-biosciences 2025-06-05T18:38:38+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-mene-la-vente-des-activites-dimmunehealth-caprion-biosciences 2025-06-05T18:38:38+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-van-de-animal-health-activiteiten-van-oystershell-uitgevoerd 2025-06-11T09:50:02+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-oystershells-animal-health-business 2025-06-11T09:50:02+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-mene-la-vente-de-lactivite-sante-animale-doystershell 2025-06-11T09:50:02+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-executeert-de-handelsverkoop-van-calxx-laboratories-aan-md-pharma 2025-06-05T18:39:16+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executes-trade-sale-calxx-laboratories-md-pharma 2025-06-05T18:39:16+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-realise-la-vente-de-calxx-laboratories-md-pharma 2025-06-05T18:39:16+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-van-qustomer-aan-ing-uitgevoerd 2025-06-11T09:53:03+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-qustomer-ing 2025-06-11T09:53:03+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-execute-la-vente-de-qustomer-ing 2025-06-11T09:53:03+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-van-labima-aan-vemedia-group-uitgevoerd 2025-06-11T09:54:20+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-labima-vemedia-group 2025-06-11T09:54:20+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-execute-la-vente-de-labima-vemedia-group 2025-06-11T09:54:20+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-realiseerde-de-verkoop-van-kntv-aan-everlasting-prod 2025-06-11T09:58:52+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-kntv-everlasting-prod 2025-06-11T09:58:52+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-realise-la-vente-de-kntv-everlasting-prod 2025-06-11T09:58:52+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-het-amerikaanse-onssi-bij-de-overname-van-seetec 2025-06-11T09:27:09+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-us-based-onssi-its-acquisition-seetec 2025-06-11T09:27:09+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-lentreprise-americaine-onssi-lors-de-lacquisition-de-seetec 2025-06-11T09:27:09+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-van-despharma-aan-omega-pharma-uitgevoerd 2025-06-11T10:02:19+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-despharma-omega-pharma 2025-06-11T10:02:19+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-execute-la-vente-de-despharma-omega-pharma 2025-06-11T10:02:19+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-afgerond-van-de-farmaceutische-activa-van-erfa-sa 2025-06-11T10:03:48+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-pharmaceutical-assets-erfa-sa 2025-06-11T10:03:48+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-finalise-la-vente-des-actifs-pharmaceutiques-derfa-sa 2025-06-11T10:03:48+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-van-de-arterin-activiteiten-van-pharco-aan-omega-pharma 2025-06-05T18:40:04+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-pharcos-arterin-business-omega-pharma-eur-10m 2025-06-05T18:40:04+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-execute-la-vente-de-lactivite-arterin-de-pharco-omega-pharma-pour-un-montant 2025-06-05T18:40:04+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-legendre-conveyors-bij-de-strategische-overname-van-belangrijke 2025-06-11T09:30:19+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-legendre-conveyors-its-strategic-takeover-key-assets-pcs 2025-06-11T09:30:19+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-legendre-conveyors-sur-lacquisition-strategique-dactifs-cles-de-pcs 2025-06-11T09:30:19+02:00 0.5 https://www.merodis.com/nl/transactions/mbo-van-altissia-merodis-trad-op-als-exclusief-adviseur-van-cll-language-centres-ucl 2025-06-05T18:40:48+02:00 0.5 https://www.merodis.com/en/transactions/mbo-altissia-merodis-acted-exclusive-advisor-cll-language-centres-ucl 2025-06-05T18:40:48+02:00 0.5 https://www.merodis.com/fr/transactions/mbo-daltissia-merodis-agi-en-tant-que-consultant-exclusif-pour-cll-language-centres 2025-06-05T18:40:48+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-telemis-bij-haar-management-buy-out 2025-06-05T18:41:07+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-telemis-its-management-buyout 2025-06-05T18:41:07+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-telemis-dans-le-cadre-de-son-rachat-par-les-cadres 2025-06-05T18:41:07+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-trad-op-als-exclusief-adviseur-bij-de-verkoop-van-e-xstream-engineering-aan 2025-06-11T09:30:56+02:00 0.5 https://www.merodis.com/en/transactions/merodis-acted-exclusive-advisor-sale-e-xstream-engineering-us-based-msc-software 2025-06-11T09:30:56+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-agi-en-tant-que-conseiller-exclusif-dans-la-vente-de-xstream-engineering-la 2025-06-11T09:30:56+02:00 0.5 https://www.merodis.com/nl/transactions/laboratoire-aerts-filot-verkocht-aan-chequers-capital 2025-06-11T09:34:12+02:00 0.5 https://www.merodis.com/en/transactions/laboratoire-aerts-filot-sold-chequers-capital 2025-06-11T09:34:12+02:00 0.5 https://www.merodis.com/fr/transactions/le-laboratoire-aerts-filot-vendu-chequers-capital 2025-06-11T09:34:12+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-exclusief-adviseur-bij-de-verkoop-van-medsys 2025-06-11T09:31:10+02:00 0.5 https://www.merodis.com/en/transactions/merodis-exclusive-advisor-sale-medsys 2025-06-11T09:31:10+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseiller-exclusif-pour-la-vente-de-medsys 2025-06-11T09:31:10+02:00 0.5 https://www.merodis.com/nl/transactions/pet-net-verkocht-aan-iba 2025-06-11T10:04:57+02:00 0.5 https://www.merodis.com/en/transactions/pet-net-sold-iba 2025-06-11T10:04:57+02:00 0.5 https://www.merodis.com/fr/transactions/pet-net-vendu-iba 2025-06-11T10:04:57+02:00 0.5 https://www.merodis.com/nl/transactions/biocode-hycel-verkocht-aan-ids 2025-06-11T09:33:30+02:00 0.5 https://www.merodis.com/en/transactions/biocode-hycel-sold-ids 2025-06-11T09:33:30+02:00 0.5 https://www.merodis.com/fr/transactions/biocode-hycel-vendu-aux-ids 2025-06-11T09:33:30+02:00 0.5 https://www.merodis.com/nl/transactions/bpl-verkocht-aan-buysse-partners 2025-06-11T09:32:58+02:00 0.5 https://www.merodis.com/en/transactions/bpl-sold-buysse-partners 2025-06-11T09:32:58+02:00 0.5 https://www.merodis.com/fr/transactions/bpl-vendue-buysse-partners 2025-06-11T09:32:58+02:00 0.5 https://www.merodis.com/nl/transactions/iba-radioisotopes-france-sas-belangrijkste-activa-verkocht-aan-cermep 2025-06-05T18:42:54+02:00 0.5 https://www.merodis.com/en/transactions/iba-radioisotopes-france-sas-key-assets-sold-cermep 2025-06-05T18:42:54+02:00 0.5 https://www.merodis.com/fr/transactions/iba-radioisotopes-france-sas-vente-des-principaux-actifs-cermep 2025-06-05T18:42:54+02:00 0.5 https://www.merodis.com/nl/transactions/fft-verkocht-aan-msc-software 2025-06-11T09:32:31+02:00 0.5 https://www.merodis.com/en/transactions/fft-sold-msc-software 2025-06-11T09:32:31+02:00 0.5 https://www.merodis.com/fr/transactions/fft-vendu-msc-software 2025-06-11T09:32:31+02:00 0.5 https://www.merodis.com/nl/transactions/pharco-verkoopt-zijn-totale-productportfolio-voor-eur-85m 2025-06-11T09:25:47+02:00 0.5 https://www.merodis.com/en/transactions/pharco-sells-its-overall-product-portfolio-eur-85m 2025-06-11T09:25:47+02:00 0.5 https://www.merodis.com/fr/transactions/pharco-vend-lensemble-de-son-portefeuille-de-produits-pour-85-millions-deuros 2025-06-11T09:25:47+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-verzekert-eur-10m-financiering-voor-gimber 2026-02-04T18:54:49+01:00 0.5 https://www.merodis.com/en/transactions/merodis-secures-eur-10m-financing-gimber 2026-02-04T18:54:49+01:00 0.5 https://www.merodis.com/fr/transactions/merodis-obtient-un-financement-de-10-millions-deuros-pour-gimber 2026-02-04T18:54:49+01:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-revive-bijgestaan-bij-de-fondsenwerving-voor-het-good-life-development 2025-05-09T14:41:03+02:00 0.5 https://www.merodis.com/en/transactions/merodis-assisted-revive-fund-raising-its-good-life-development-fund-ii 2025-05-09T14:41:03+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-assiste-revive-dans-sa-collecte-de-fonds-pour-le-good-life-development-fund-ii 2025-05-09T14:41:03+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-treedt-op-als-arranger-bij-de-private-plaatsing-van-een-eur5m-5y-note-voor 2025-04-25T16:33:29+02:00 0.5 https://www.merodis.com/en/transactions/merodis-acts-arranger-private-placement-eur5m-5y-note-atenor 2025-04-25T16:33:29+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-intervient-en-tant-quarrangeur-dans-le-placement-prive-dune-obligation-5-ans 2025-04-25T16:33:29+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-begeleidt-pom-nv-bij-haar-financieringsronde 2025-04-24T17:54:02+02:00 0.5 https://www.merodis.com/en/transactions/merodis-assists-pom-nv-its-financing-round 2025-04-24T17:54:02+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-accompagne-pom-nv-dans-son-cycle-de-financement 2025-04-24T17:54:02+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-begeleidt-kebony-bij-financieringsronde-van-10-miljoen-eur 2025-04-24T18:38:04+02:00 0.5 https://www.merodis.com/en/transactions/merodis-assists-kebony-its-eur-10m-financing-round 2025-04-24T18:38:04+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-accompagne-kebony-dans-un-tour-de-table-de-10-millions-deuros 2025-04-24T18:38:04+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-begeleidt-fng-bij-kapitaalverhoging-van-30-miljoen-eur 2025-04-24T18:00:47+02:00 0.5 https://www.merodis.com/en/transactions/merodis-assists-fng-its-eur-30m-capital-raise 2025-04-24T18:00:47+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-assiste-fng-dans-une-augmentation-de-capital-de-30-millions-deuros 2025-04-24T18:00:47+02:00 0.5 https://www.merodis.com/nl/transactions/3-miljoen-euro-financieringspakket-voor-tehr 2025-04-24T18:03:01+02:00 0.5 https://www.merodis.com/en/transactions/eur-3m-financing-package-tehr 2025-04-24T18:03:01+02:00 0.5 https://www.merodis.com/fr/transactions/financement-de-3-millions-deuros-pour-tehr 2025-04-24T18:03:01+02:00 0.5 https://www.merodis.com/nl/transactions/kapitaalverhoging-van-6-miljoen-euro-voor-kiomed-pharma 2025-04-24T18:04:14+02:00 0.5 https://www.merodis.com/en/transactions/eur-6m-capital-increase-kiomed-pharma 2025-04-24T18:04:14+02:00 0.5 https://www.merodis.com/fr/transactions/augmentation-de-capital-de-6-millions-deuros-pour-kiomed-pharma 2025-04-24T18:04:14+02:00 0.5 https://www.merodis.com/nl/transactions/pp-nu-beschikbaar 2025-04-24T18:27:28+02:00 0.5 https://www.merodis.com/en/transactions/pp-now-available 2025-04-24T18:27:28+02:00 0.5 https://www.merodis.com/fr/transactions/pp-maintenant-disponible 2025-04-24T18:27:28+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-sophia-genetics-bij-haar-serie-c-financiering-van-chf-15m 2025-04-24T18:11:08+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-sophia-genetics-its-chf-15m-series-c-financing 2025-04-24T18:11:08+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-sophia-genetics-pour-son-financement-de-serie-c-de-chf-15-millions 2025-04-24T18:11:08+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-biosourcing-succesvol-bij-kapitaalverhoging 2025-04-24T18:09:59+02:00 0.5 https://www.merodis.com/en/transactions/merodis-successfully-advises-biosourcing-its-capital-increase 2025-04-24T18:09:59+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-avec-succes-biosourcing-dans-le-cadre-dune-augmentation-de-capital 2025-04-24T18:09:59+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseerde-c3bs-bij-de-investering-van-eur-95m-van-pmv 2025-04-24T18:14:18+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advised-c3bs-related-eur-95m-investment-pmv 2025-04-24T18:14:18+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-c3bs-sur-linvestissement-de-95-millions-deuros-de-pmv 2025-04-24T18:14:18+02:00 0.5 https://www.merodis.com/nl/transactions/brandialog-financiering-private-placement 2025-04-22T14:31:50+02:00 0.5 https://www.merodis.com/en/transactions/brandialog-financing-through-private-placement 2025-04-22T14:31:50+02:00 0.5 https://www.merodis.com/fr/transactions/brandialog-financement-par-placement-prive 2025-04-22T14:31:50+02:00 0.5 https://www.merodis.com/nl/transactions/yago-schuldfinanciering-private-placement 2025-04-22T14:45:55+02:00 0.5 https://www.merodis.com/en/transactions/yago-debt-financing-through-private-placement 2025-04-22T14:45:55+02:00 0.5 https://www.merodis.com/fr/transactions/yago-financement-par-la-dette-un-placement-prive 2025-04-22T14:45:55+02:00 0.5 https://www.merodis.com/nl/transactions/pharco-haalt-eur-15m-aan-schuldfinanciering-op-en-tekent-een-commercieel-partnerschap 2025-04-24T18:32:41+02:00 0.5 https://www.merodis.com/en/transactions/pharco-raises-eur-15m-debt-financing-and-signs-commercial-partnership 2025-04-24T18:32:41+02:00 0.5 https://www.merodis.com/fr/transactions/pharco-leve-15-million-deuros-de-financement-et-signe-un-partenariat-commercial 2025-04-24T18:32:41+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-treedt-op-als-arranger-bij-de-private-plaatsing-van-een-eur5m-5y-note-voor-0 2025-04-25T16:34:18+02:00 0.5 https://www.merodis.com/en/transactions/merodis-acts-arranger-private-placement-eur5m-5y-note-atenor-0 2025-04-25T16:34:18+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-intervient-en-tant-quarrangeur-dans-le-placement-prive-dun-billet-de-5 2025-04-25T16:34:18+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-treedt-op-als-arranger-bij-de-onderhandse-plaatsing-van-een-obligatielening 2025-04-25T16:35:06+02:00 0.5 https://www.merodis.com/en/transactions/merodis-acts-arranger-private-placement-eur-5m-bond-audiovalley 2025-04-25T16:35:06+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-intervient-en-tant-quarrangeur-dans-le-placement-prive-dun-emprunt-obligataire 2025-04-25T16:35:06+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-begeleidt-fintech-koalaboox-bij-plaatsing-obligatielening-van-13-miljoen-euro 2025-05-14T17:03:17+02:00 0.5 https://www.merodis.com/en/transactions/merodis-assists-fintech-koalaboox-its-eur-13-million-bond-placing 2025-05-14T17:03:17+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-accompagne-la-fintech-koalaboox-dans-un-placement-obligataire-de-13-millions 2025-05-14T17:03:17+02:00 0.5 https://www.merodis.com/nl/transactions/groupe-bertrand-schuldfinanciering-private-plaatsing 2025-04-22T14:59:03+02:00 0.5 https://www.merodis.com/en/transactions/groupe-bertrand-debt-financing-through-private-placement 2025-04-22T14:59:03+02:00 0.5 https://www.merodis.com/fr/transactions/groupe-bertrand-financement-de-la-dette-par-placement-prive 2025-04-22T14:59:03+02:00 0.5 https://www.merodis.com/nl/transactions/hld-europe-schuldfinanciering-private-placement 2025-04-22T14:58:46+02:00 0.5 https://www.merodis.com/en/transactions/hld-europe-debt-financing-through-private-placement 2025-04-22T14:58:46+02:00 0.5 https://www.merodis.com/fr/transactions/hld-europe-financement-de-la-dette-par-placement-prive 2025-04-22T14:58:46+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-familie-verhaeren-bij-de-verkoop-van-haar-50-belang-viabuild-aan 2025-06-05T18:33:11+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-verhaeren-family-sale-its-50-stake-viabuild-square-group 2025-06-05T18:33:11+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-la-famille-verhaeren-sur-la-vente-de-sa-participation-de-50-dans 2025-06-05T18:33:11+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-verkoop-vesale-pharma-aan-ceres-pharma 2025-08-08T15:07:06+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-sale-vesale-pharma-ceres-pharma 2025-08-08T15:07:06+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-la-vente-de-vesale-pharma-ceres-pharma 2025-08-08T15:07:06+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-alluvion-bij-de-verkoop-aan-amista 2025-08-07T12:57:01+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-alluvion-its-sale-amista 2025-08-07T12:57:01+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-alluvion-dans-sa-vente-amista 2025-08-07T12:57:01+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-heeft-de-verkoop-uitgevoerd-van-vemedias-abc-chemicals 2025-09-01T16:37:28+02:00 0.5 https://www.merodis.com/en/transactions/merodis-executed-sale-vemedias-abc-chemicals 2025-09-01T16:37:28+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-execute-la-vente-de-la-division-abc-chemicals-de-vemedia 2025-09-01T16:37:28+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-nexum-bij-de-fusie-met-proacteur-met-steun-van-profinpar-een-nieuwe 2025-09-01T16:47:39+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-nexums-merger-proacteur-support-profinpar-new-minority-shareholder 2025-09-01T16:47:39+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-nexum-sur-la-fusion-avec-proacteur-avec-le-soutien-de-profinpar-un 2025-09-01T16:47:39+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-group-bij-de-verkoop-aan-network-aviation-group 2025-10-17T17:09:17+02:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-group-its-sale-network-aviation-group 2025-10-17T17:09:17+02:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-group-dans-sa-vente-network-aviation-group 2025-10-17T17:09:17+02:00 0.5 https://www.merodis.com/nl/transactions/merodis-adviseert-laroy-group-bij-strategisch-partnership-met-group-depre 2026-02-04T17:04:28+01:00 0.5 https://www.merodis.com/en/transactions/merodis-advises-laroy-group-strategic-partnership-group-depre 2026-02-04T17:04:28+01:00 0.5 https://www.merodis.com/fr/transactions/merodis-conseille-le-groupe-laroy-dans-le-cadre-de-son-partenariat-strategique-avec-le 2026-02-04T17:04:28+01:00 0.5